TGFB1 and Uterine leiomyoma: The viability of uterine leiomyoma cells decreased to 67%, 59%, 27%, and 29% after treatment with UPA, mifepristone, TGF-β1 inhibitor, and VEGF inhibitor, respectively, compared to the untreated control.